Navigation Links
Collagen manufactured from transgenic tobacco plants at Hebrew University
Date:6/10/2010

Jerusalem, June 10, 2010 A scientist at the Hebrew University of Jerusalem's Robert H. Smith Faculty of Agriculture, Food and Environment has succeeded in producing a replica of human collagen from tobacco plants an achievement with tremendous commercial implications for use in a variety of human medical procedures.

Natural human type I collagen is the most abundant protein in the human body and is the main protein found in all connective tissue. Commercially produced collagen (pro-collagen) is used in surgical implants and many wound healing devices in regenerative medicine. The current market for collagen-based medical devices in orthopedics and wound healing exceeds US $30 billion annually worldwide.

Currently, commercial collagen is produced from farm animals such as cows and pigs as well as from human cadavers. These materials are prone to harbor human pathogens such as viruses or prions (mad-cow disease). Human cadaver is scarce, and for certain indications possesses serious ethical issues.

Producing human recombinant type I pro-collagen requires the coordinated expression of five different genes. Prof. Oded Shoseyov of the Robert H. Smith Institute of Plant Sciences and Genetics in Agriculture has established the only laboratory in the world that has reported successful co-expression all the five essential genes in transgenic tobacco plants for the production of processed pro-collagen. For this work, Shoseyov was one of the recipients of a Kaye Innovation Award during the Hebrew University Board of Governors meeting in June.

Shoseyov's invention on has been patented, and the scientific findings behind it were published recently in the journal Biomacromolecules. A company, CollPlant Ltd., has been established based on patents and technology that were developed in Shoseyov's laboratory. It has raised US$15 million to establish the first commercial molecular farming company in Israel and is already manuf
'/>"/>

Contact: Jerry Barach
jerryb@savion.huji.ac.il
972-258-82904
The Hebrew University of Jerusalem
Source:Eurekalert  

0

GOOD

Page: 1 2

Related medicine news :

1. Hard to Treat Diseases (HTDS) Collagenna Skin Care Business Model and Chilean Update
2. UCSF Transgenic Mouse Mimics Parkinson's Earliest Symptoms
3. Tobacco tax hike could curb smoking among those with alcohol, drug or mental disorders
4. UCSF Analyses Detail Tobacco Industry Influence on Health Policy
5. Women Smokers Targeted on World No Tobacco Day
6. Celebrate The World Health Organization's World No Tobacco Day, and Get Free eBook - Protect Women from Tobacco Marketing and Smoke
7. UCSF analyses detail tobacco industry influence on health policy
8. Scientific Study Reveals that 79 Percent of Electronic Cigarette Users Have Stopped or Reduced Their Tobacco Use
9. NYU College of Dentistry, Penn State develop new model for investigating tobacco/oral cancer link
10. Researchers demonstrate that safe cigarettes are as hazardous as tobacco
11. African-American infants at increased risk from tobacco smoke exposure
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Collagen manufactured from transgenic tobacco plants at Hebrew University
(Date:5/20/2013)... 20, 2013 The US Drug ... of a transvaginal mesh failure, we are now calling ... we have ever seen for women, and the damages ... a potentially huge number of US women. According to ... underwent procedures in which mesh was implanted vaginally to ...
(Date:5/20/2013)... The Semi Truck Accident Victims Center ... service for an innocent victim of a catastrophic semi ... our services are unparalleled. What this means is if ... of a passenger vehicle involved in a semi truck ... Ohio, New Jersey, Indiana, Maryland, Georgia, Nebraska, Kansas, Michigan, ...
(Date:5/20/2013)... Toronto, ON (PRWEB) May 20, 2013 ... hosted VoIP, Video, Data and IT Security solution ... video series aimed at providing business customers ... return of investments in BroadConnect services. With the ... product managers offer valuable insight into some of ...
(Date:5/20/2013)... 20, 2013 On May 14th, premiere ... testimonial about how one of its patients originally came ... after being diagnosed with giant papillary conjunctivitis. “Giant papillary ... the eye, and for one of our patients in ... allergy,” says the Medical Director of the Atlanta Vision ...
(Date:5/20/2013)... AlignLife of Waunakee is proud to announce ... the Tri-4-Schools children’s triathlon. Tri-4-Schools is a nonprofit organization ... kids active and fight childhood obesity. Their events aim ... nutrition, sportsmanship and self-confidence. Tri-4-Schools hopes to instill the ... and under so they can make healthy choices that ...
Breaking Medicine News(10 mins):Health News:US Drug Watchdog Now Urges Transvaginal Mesh Failure Victims With Erosion To Call Them For The Names And Contacts Of The Best Women Attorneys 2Health News:Semi Truck Accident Victims Center Urges Family Members Of Victims Injured In A Horrific Semi Truck Accident In Any US State To Call Them First For An Unsurpassed Response 2Health News:BroadConnect’s Latest Video Solution Sets Aimed at Providing Technical Insights for Businesses Hoping to Gain Greater Returns from their Investment in Communication and Security Solutions 2Health News:Atlanta LASIK Practice Publishes a Patient’s Testimonial About Allergy to Contact Lenses 2
... replacement care, according to Dr. Xueya Cai and colleagues ... work, published online in Springer,s journal Clinical Orthopaedics and ... likely than Caucasians to receive total knee arthroplasty (or ... is widely performed in patients of all races with ...
... , TUESDAY, Sept. 13 (HealthDay News) --,Two decades after the ... abnormalities in their brains that in some cases have even ... part of a debilitating disorder known as Gulf War illness. ... to be caused by exposure to neurotoxins and nerve gas. ...
... study finds that infections following cardiac device implantations or ... in terms of patient mortality, even months after affected ... led to 4.8 to 7.7-fold increases in admission mortality, ... 4.0-fold increases in hospital length of stay, and 1.4 ...
... Chicago Many patients are responding to a new, ... out the bad cells. Atrial fibrillation (A-Fib) is one ... arrhythmia affecting Americans. However, new research shows that 70 ... with cryoballoon ablation, the freezing technique, are free of ...
... Steele HealthDay Reporter , MONDAY, Sept. 12 ... help people with mild memory problems or early Alzheimer,s ... small study suggests. But, the study authors added, ... therapy will actually benefit patients. Alzheimer,s disease, the ...
... WINSTON-SALEM, N.C. September 12, 2011 A year ... listening to doctor,s orders when it comes to taking ... of Wake Forest Baptist Medical Center shows. However, there ... "Medication non-compliance is a major risk factor for stroke ...
Cached Medicine News:Health News:Does race dictate quality of care? 2Health News:Brain Blood Flow Abnormalities Persist in Gulf War Vets 2Health News:Costs, mortality skyrocket following infection in cardiac device recipients 2Health News:Freeze and desist: Disabling cardiac cells that can cause arrhythmia 2Health News:Insulin Spray May Improve Alzheimer's Symptoms 2Health News:Insulin Spray May Improve Alzheimer's Symptoms 3Health News:Researchers focus on secondary stroke prevention after study reveals room for improvement 2Health News:Researchers focus on secondary stroke prevention after study reveals room for improvement 3Health News:Researchers focus on secondary stroke prevention after study reveals room for improvement 4
(Date:5/17/2013)... , May 17, 2013  Sanofi (EURONEXT: SAN and ... pivotal study, JAKARTA , examining the ... primary endpoint in both dose groups. The primary endpoint ... spleen volume. Consistent with data reported in previous trials, ... and vomiting. Full results will be presented at an ...
(Date:5/17/2013)... Sinovac Biotech Ltd. (Nasdaq: SVA ), a leading ... announced that it will release its unaudited financial results for ... Tuesday, May 28, 2013.  The Company will host a conference ... (May 28, 2013 at 8:00 p.m. China Standard Time) to ... recent corporate developments. To access the conference call, ...
(Date:5/16/2013)... and ZURICH , May 17, ... Agency for Science, Technology and Research (A*STAR) and ... first healthy volunteer has been dosed in a Phase 1 ... Cytos, proprietary bacteriophage Qbeta virus-like particle (VLP) technology. In this ... this novel vaccine candidate and its potential to protect against ...
Breaking Medicine Technology:Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6
... 2007 -- CytImmune, a,clinical stage nanomedicine company ... therapies has,been selected to present a poster abstract ... Meeting in Chicago Illinois,June 1-5. The poster session ... on June 3. Dr. Lawrence Tamarkin, CEO of ...
... in Journal of Cell Science Shows ONCONASE Uptake ... 05, 2007 /PRNewswire-FirstCall/ --,Alfacell Corporation today announced that ... follows to enter,cells. , Published in the Journal ... on studies conducted at the University of Girona ...
Cached Medicine Technology:CytImmune To Present At ASCO Phase I Clinical Trial of CYT-6091 to,be Presented on June 3, 2007 2Researchers Identify Intracellular Pathway of Alfacell's Onconase 2Researchers Identify Intracellular Pathway of Alfacell's Onconase 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: